-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
InMed Pharmaceuticals Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate for Q3 2022.
- InMed Pharmaceuticals Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2022 was $6.8K.
- InMed Pharmaceuticals Inc. annual Income Tax Expense (Benefit) for 2024 was $7.1K, a 45.8% decline from 2023.
Income Tax Expense (Benefit), Quarterly (USD)